Glutathione S-transferase polymorphisms in patients with drug eruption

Glutathione S-transferase (GST) enzymes play an important role in drug metabolism. GST is a multigene family of enzymes involved in the detoxification and in a few instances activation of a wide variety of chemicals. Detoxification features make it plausible to search for GST polymorphism in patient...

Full description

Saved in:
Bibliographic Details
Published inArchives of Dermatological Research Vol. 295; no. 10; pp. 429 - 433
Main Authors Ateş, Nurcan Aras, Tursen, Umit, Tamer, Lülüfer, Kanik, Arzu, Derici, Ebru, Ercan, Bahadir, Atik, Ugur
Format Journal Article
LanguageEnglish
Published Germany 01.03.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Glutathione S-transferase (GST) enzymes play an important role in drug metabolism. GST is a multigene family of enzymes involved in the detoxification and in a few instances activation of a wide variety of chemicals. Detoxification features make it plausible to search for GST polymorphism in patients with drug eruption. The GSTM (mu), GSTT (theta) and GSTP (pi) have been shown to be polymorphically distributed. The GSTT1, GSTM1 and GSTP1 gene polymorphism were detected using real-time PCR. GSTM1 and GSTT1 null genotypes were found to be associated with an increased risk of drug eruption (OR 2.27, 95% CI 1.20-5.21; OR 2.48, 95% CI 1.12-6.39, respectively). No relationship was observed between the null combination of the GSTM1 and GSTT1 genotype polymorphisms and drug eruption risk (OR 2.65, 95% CI 0.62-11.25). Our results show that GSTP1 polymorphism is not a significant contributor to drug eruption risk. The GSTM1 and GSTT1 gene polymorphisms seem to be associated with the development of drug eruption. Further studies may shed additional light on the role of GSTM1, GSTT1 and GSTP1 in drug eruption.
ISSN:0340-3696
1432-069X
DOI:10.1007/s00403-003-0446-z